ABT vs STE
Abbott Laboratories (ABT) and Steris (STE) compared side by side. Abbott Laboratories (ABT) is larger, with a market cap of $179.4B versus $22.6B for Steris, about 7.9 times the size. On trailing earnings, STE is cheaper at 28.4x versus 38.6x for ABT.
Head to head
| Metric | ABT | STE |
|---|---|---|
| Market cap | $179.4B | $22.6B |
| P/E (TTM) | 38.6x | 28.4x |
| Forward P/E | 17.4x | 18.8x |
| Revenue (TTM) | $48.2B | — |
| Revenue growth | 14.5% | — |
| Gross margin | 57.1% | — |
| Operating margin | 11.3% | — |
| Free cash flow | $7.4B | $925.6M |
| Dividend yield | 2.43% | 1.11% |
| 1-year return | -15.9% | -3.2% |
| 5-year return (annual) | -2.0% | +0.7% |
| Max drawdown | -46% | -77% |
| FI Handbook grade | C+ | C+ |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
ABT vs STE FAQ
Which is bigger, ABT or STE?
Abbott Laboratories (ABT) is larger, with a market cap of $179.4B versus $22.6B for Steris, about 7.9 times the size.
Is ABT or STE cheaper?
On trailing earnings, STE is cheaper at 28.4x versus 38.6x for ABT. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, ABT or STE?
STE returned -3.2% over the past year including dividends, versus -15.9% for ABT, through October 23, 2026.
Which pays a higher dividend, ABT or STE?
ABT yields 2.43% versus 1.11% for STE.
Full pages: Abbott Laboratories · Steris